Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering and developing b

08/17/2023

Lexicon Legends highlights employees that have made important contributions to the company, their communities, or the world at large by putting our values into action. We’re proud to recognize Bridget Wagner, Executive Legal Assistant.

05/11/2023

Lexicon Legends highlights employees that have made important contributions to the company, their communities, or the world at large by putting our values into action.

We’re proud to recognize Winston Churchill, Director, Commercial Access-Federal Accounts. .

02/16/2023

Today’s theme for Heart Failure Awareness Week is “HF Challenges.” Rehospitalizations for heart failure are one of the leading challenges for patients and those who care for them.

Learn more about : bit.ly/3YcEQkl

02/15/2023

Did you know that the vast majority of total heart failure costs are related to hospitalizations? It’s Heart Failure Awareness Week, and today’s focus is on how patients, family and caregivers manage heart failure.

Learn more about : bit.ly/3YcEQkl

02/14/2023

Lexicon Legends highlights employees that have made important contributions to the company, their communities, or the world at large by putting our values into action. We’re proud to recognize Michael J. Davies, PhD, Executive Director, Clinical Development, as a .

02/13/2023

It’s Heart Failure Awareness Week! Today we’re highlighting the large number of people receiving in-patient care and the financial costs associated with hospitalizations.

Learn more about : bit.ly/3YcEQkl

02/10/2023

Heart Failure Awareness Week kicks off Monday, February 12th! Join us in supporting the Heart Failure Society of America’s mission of educating and empowering the HF community.

Learn more about : bit.ly/3YcEQkl

Lexicon Announces Topline Results from Phase 2 Proof-Of-Concept Study of LX9211 in Postherpetic Neuralgia. To view the f...
12/21/2022

Lexicon Announces Topline Results from Phase 2 Proof-Of-Concept Study of LX9211 in Postherpetic Neuralgia. To view the full press release, visit our website: bit.ly/3FPHTXk

Our SVP & Chief Medical Officer, Dr. Craig Granowitz, presented at the 19th Global Cardiovascular Clinical Trialists For...
12/05/2022

Our SVP & Chief Medical Officer, Dr. Craig Granowitz, presented at the 19th Global Cardiovascular Clinical Trialists Forum. If you missed it, you can read about the topic covered here: bit.ly/3E7zBL8

12/04/2022

We’ll be attending the American Society for Hospital Pharmacists Midyear Clinical Meeting. Learn more and register here: bit.ly/3V1bRhs

12/03/2022

We’re looking forward to attending the 3rd annual Going Back to the Heart of Cardiology meeting. Learn more and register here: bit.ly/3gwaF72

12/02/2022

We’re looking forward to engaging with everyone at the 19th Global Cardiovascular Clinical Trialists Forum. We invite you to read about data we’ll be discussing: bit.ly/3E7zBL8

Address

2445 Technology Forest Boulevard, 11th Floor
The Woodlands, TX
77381

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+12818633000

Website

Alerts

Be the first to know and let us send you an email when Lexicon Pharmaceuticals, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lexicon Pharmaceuticals, Inc.:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram